Genscript Biotech Corporation (G51) — Free Cash Flow Generation Index
Genscript Biotech Corporation (G51) has a Free Cash Flow Generation Index of 1.00x as of December 2019. Free cash flow of €61.62 Million represents 1% of operating cash flow (€61.62 Million). Read G51 total debt and obligations for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Genscript Biotech Corporation Free Cash Flow Generation Index (2016–2025)
Historical FCF Generation Index trend for Genscript Biotech Corporation across 5 annual periods. Explore Genscript Biotech Corporation capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Genscript Biotech Corporation (2016–2025)
Year-by-year Free Cash Flow Generation Index for Genscript Biotech Corporation. For the full company profile including market capitalisation, see G51 company net worth.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.74x | €241.69 Million | €325.52 Million | €83.84 Million | ▲ +177.7% |
| 2024 | -0.96x | €-72.27 Million | €75.65 Million | €147.92 Million | ▼ -236.2% |
| 2018 | 0.70x | €215.80 Million | €307.66 Million | €70.84 Million | ▲ +241.4% |
| 2017 | -0.50x | €-10.60 Million | €21.37 Million | €29.21 Million | ▼ -139.1% |
| 2016 | 1.27x | €42.26 Million | €33.27 Million | €8.98 Million | — |